The pharmaceutical giant expressed optimism that its new flu shot would be available this year, after approval concerns.
US to Review Moderna's Flu Vaccine After Initial Decline
The US government has announced it will review Moderna's flu vaccine, which was previously declined. Moderna is optimistic about the vaccine's availability this year following approval concerns.
AI Summary
The US government has announced it will review Moderna's flu vaccine, which was previously declined. Moderna is optimistic about the vaccine's availability this year following approval concerns.
FAQs
The initial decline was due to concerns regarding the vaccine's safety and efficacy.
Moderna is optimistic that its flu vaccine will be available this year following the review.
The specific timeline for the review has not been disclosed, but it is expected to occur soon.
If approved, the vaccine could provide an additional option for flu prevention.
The review could lead to more effective flu prevention strategies if the vaccine is approved.
Cite this article
<a href="https://desdunia.com/world/us-says-that-it-will-review-moderna-flu-vaccine-it-previously-declined" target="_blank" rel="nofollow noopener">US to Review Moderna's Flu Vaccine After Initial Decline</a> (Desdunia, 2026-02-18)
[US to Review Moderna's Flu Vaccine After Initial Decline](https://desdunia.com/world/us-says-that-it-will-review-moderna-flu-vaccine-it-previously-declined) — Desdunia (2026-02-18)
https://desdunia.com/world/us-says-that-it-will-review-moderna-flu-vaccine-it-previously-declined
<blockquote cite="https://desdunia.com/world/us-says-that-it-will-review-moderna-flu-vaccine-it-previously-declined">US to Review Moderna's Flu Vaccine After Initial Decline</blockquote>
<p>Source: <a href="https://desdunia.com/world/us-says-that-it-will-review-moderna-flu-vaccine-it-previously-declined" target="_blank" rel="nofollow noopener">Desdunia</a></p>